Subtype‐Specific Causal Effects of C16 and C24 Ceramides on Heart Failure: Evidence From Univariable and Multivariable Mendelian Randomization Analyses
Ceramides (Cer) are bioactive lipids implicated in cardiovascular disease (CVD), yet their subtype‐specific causal effects remain unclear. We performed a two‐sample Mendelian randomization (MR) analysis using publicly available GWAS summary statistics to investigate the effects of C16:0‐ceramide homologs (Cer16:0) and C24:1‐ceramide homologs (Cer24:1) on six CVD outcomes. Instrumental variables were rigorously selected, and multiple MR methods were applied to ensure robust inference. Univariable MR identified a significant inverse association between Cer(d18:1/24:1) and heart failure (HF), which remained significant after false discovery rate correction. In contrast, the association for Cer(d17:1/16:0) did not remain significant after correction. No causal associations were observed for other CVD outcomes. When aggregating subtypes, genetically predicted higher total Cer16:0 levels were associated with increased HF risk, while no significant association was found for total Cer24:1. Multivariable MR further demonstrated that the protective effect of Cer(d18:1/24:1) on HF was robust, while estimates for C16 subtypes were attenuated and sensitive to model specification. In conclusion, our findings support a stable protective role of Cer(d18:1/24:1) in HF and highlight the complexity of subtype‐specific effects among structurally related ceramides. These results underscore the importance of considering ceramide heterogeneity in cardiovascular research. Further studies are warranted to validate these findings and explore their clinical implications.
No keywords indexed for this article. Browse by subject →
Jack Bowden, George Davey Smith, Philip C. Haycock et al.
J. Bowden, G. Davey Smith, S. Burgess
Karmel W. Choi, Chia-Yen Chen, Murray B. Stein et al.
Connor A. Emdin, Amit V. Khera, Sekar Kathiresan
Rozenn N. Lemaitre, Paul N. Jensen, Andrew Hoofnagle et al.
The Emerging Risk Factors Collaboration*
Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe et al.
Salim S. Virani, Alvaro Alonso, Emelia J. Benjamin et al.
Showing 50 of 55 references
- Published
- Apr 06, 2026
- License
- View
You May Also Like
Ken’ichi Ichihara, Akira Shibahara · 1996
367 citations
Jana Kraft, Marius Collomb · 2003
182 citations
J. Gordon Bell, Douglas R. Tocher · 1997
175 citations